Nurses make an amazing impact in patient care and they have been on the front-lines caring for #COVID-19 patients. However, they have not always been provided with what they need in terms of education and PPEs. Moreover, nurses have been told not to speak to media orb they might risk losing their jobs. I was fortunate to host two nurses on this product; both requested to be anonymous. One is from Chicago and the other is from California. They joined me to discuss when their institutions began preparing for an influx of COVID-19 patients, conflicting information from their institutions regarding PPE supplies, ease of complying with CDC/WHO guidelines for sanitizing used PPEs, and more.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
